Jaime Imitola

Affiliations: 
Ohio State University, Columbus, OH, United States 
Area:
Neural stem cells and Neuroimmunology
Google:
"Jaime Imitola"
Mean distance: 16.93 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Starossom SC, Campo Garcia J, Woelfle T, et al. (2019) Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation. Nature Communications. 10: 217
Ryan KJ, White CC, Patel K, et al. (2017) A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Science Translational Medicine. 9
Bowman M, Racke M, Kissel J, et al. (2015) Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor. Jama Neurology. 72: 1342-5
Imitola J, Khurana DS, Teplyuk NM, et al. (2015) A novel 2q37 microdeletion containing human neural progenitors genes including STK25 results in severe developmental delay, epilepsy, and microcephaly. American Journal of Medical Genetics. Part A
Merzaban JS, Imitola J, Starossom SC, et al. (2015) Cell Surface Glycan Engineering of Neural Stem Cells Augments Neurotropism and Improves Recovery in a Murine Model of Multiple Sclerosis. Glycobiology
Imitola J, Wagoner J, Khurana JS. (2015) Rapid dissemination of granular cell astrocytoma arising from periventricular stem cell regions in chronic multiple sclerosis. Journal of Neuro-Oncology. 124: 147-9
Rasouli J, Ciric B, Imitola J, et al. (2015) Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy. Journal of Immunology (Baltimore, Md. : 1950). 194: 5085-93
Orack JC, Deleidi M, Pitt D, et al. (2015) Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration. Stem Cells Translational Medicine. 4: 252-60
Imitola J, Racke MK. (2015) Is no evidence of disease activity a realistic goal for patients with multiple sclerosis? Jama Neurology. 72: 145-7
Durvasula S, Imitola J. (2015) The cerebrospinal fluid-stem cell interactions as target for regenerative therapy in neurological diseases. Stem Cells and Development. 24: 145-6
See more...